EMA Authorised: Ekterly (sebetralstat) — Kalvista Pharmaceuticals (Ireland) Limited

View source ↗

Summary

Ekterly (sebetralstat) has been authorised in the EU for hereditary angioedema, with Kalvista Pharmaceuticals (Ireland) Limited as the marketing authorization h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• EKTERLY (SEBETRALSTAT)

Snippet

Status: Authorised. Therapeutic area: Angioedemas, Hereditary. MAH: Kalvista Pharmaceuticals (Ireland) Limited. Decision date: 13/07/2026. Orphan medicine